ImmunityBio, Inc. Banner Image

ImmunityBio, Inc.

  • Ticker IBRX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
ImmunityBio, Inc. Logo Image
  • 501-1000 Employees
  • Based in San Diego, California
ImmunityBio is a vertically-integrated, clinical-stage biotechnology company developing next-generation therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. The company’s range of immunotherapy and cell therapy platforms, alone and together, act to drive and sustain an immune response with the goal of creating durable and safe protectionMore against disease. These platforms and their associated product candidates are designed to be more effective, accessible, and easily administered than current standards of care in oncology and infectious diseases.
4.7 / 5.0 (264)

ImmunityBio, Inc. reports have an aggregate usefulness score of 4.7 based on 264 reviews.

ImmunityBio, Inc.

Most Recent Annual Report

ImmunityBio, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

ImmunityBio, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!